This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


Autodisable syringe gap analysis

This document, current as of November 11, 2021, provides data and information from PATH's COVID-19 modeling focused on the global autodisable (AD) syringe supply gap. This current forecast shows a gap of more than 1 billion safety syringes that could impact immunization efforts in 100 countries. The AD syringe gap analysis combines syringe supply capacity collected from manufacturers with estimated syringe demand from all countries known to use AD syringes globally, including demand for both COVID-19 and non-COVID-19 immunizations. The demand forecast for COVID-19 vaccination syringes is based on projected vaccine availability through the end of 2022 and includes secured bilateral deals, COVAX deals, donations, and other multilateral deals.

Publication date: November 2021

Autodisable syringe gap analysis

116.4 KB PDF
View Resource